TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 3 | 1 | 4 | -1 | -5 | -4 | -7 | 16 | 6 | 1 |
| S | %wins | 50 | 100 | 100 | 100 | 50 | 0 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/5/17 13:14 | 4/4/17 | MULE | Mulesoft, Inc | DE | Tech | Softw | Prepackaged Software | Bain Capital Public Equity Management, LLC | MA | T | S | -259 | 23.85 | 33 | -11 | -1 | 1,583 | I | 5 | 0 | 1 | -6 | -7 | ||||||||||
3/31/17 20:13 | 3/22/17 | MULE | Mulesoft, Inc | DE | Tech | Softw | Prepackaged Software | Bain Capital Public Equity Management, LLC | MA | T | S.am | -6,079 | 23.27 | 33 | -261 | -27 | 703 | I | -1 | 6 | 1 | -3 | -5 | ||||||||||
4/11/14 18:30 | 3/11/14 | DRNA | Dicerna Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Brookside Capital Management LLC | MA | T | S.m | -29,172 | 37.11 | 7 | -786 | -34 | 1,551 | I | -46 | -47 | -26 | -11 | -6 | -9 | -3 | -1 | -30 | 3 | |||||
3/6/12 17:26 | 7/28/11 | NSPH | Nanosphere Inc | DE | Health | MdEq | Surgical & Medical Instrument | Brookside Capital Management LLC | MA | T | S.m | -1,901 | 2.13 | 0 | -893 | -20 | 3,580 | I | -39 | -34 | 50 | 27 | 29 | 16 | 2 | -4 | 0 | -1 | 0 | -13 | 62 | 9 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |